Potent benzimidazolone based human β3-adrenergic receptor agonists

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 21, 2006, Pages 5691-5694

  Finley, Don R ^a   Bell, Michael G ^a   Borel, Anthony G ^a   Bloomquist, William E ^a   Cohen, Marlene L ^a   Heiman, Mark L ^a   Kriauciunas, Aidas ^a   Matthews, Donald P ^a   Miles, Tania ^a   Neel, David A ^a   Rito, Christopher J ^a   Sall, Daniel J ^a   Shuker, Anthony J ^a   Stephens, Thomas W ^a   Tinsley, Frank C ^a   Winter, Mark A ^a   Jesudason, Cynthia D ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Benzimidazolone; Beta 1 receptors; Beta 3 agonists; Obesity; Tachycardia

Indexed keywords

4 (3 AMINO 2 HYDROXYPROPOXY) 1,3 DIHYDROBENZOIMIDAZOL 2 ONE; 4 HYDROXY 1 METHYL 1,3 DIHYDROBENZOIMIDAZOL 2 ONE; 4 HYDROXY 1,3 DIMETHYL 1,3 DIHYDROBENZOIMIDAZOL 2 ONE; BENZIMIDAZOLE DERIVATIVE; BENZIMIDAZOLONE DERIVATIVE; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG SYNTHESIS; NONHUMAN; RAT;

ADRENERGIC BETA-3 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-AGONISTS; BENZIMIDAZOLES; HUMANS; RECEPTORS, ADRENERGIC, BETA-3;

EID: 33748796698     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.08.010     Document Type: Article

References (30)

1. Germack R., Starzec A.B., Vassy R., and Perret G.Y. Br. J. Pharmacol. 120 (1997) 201
2. Llado I., Estrany M.E., Rodriguez E., Amengual B., Roca P., and Palou A. Int. J. Obes. 24 (2000) 1396
3. Lowell B.B., and Flier J.S. Annu. Rev. Med. 48 (1997) 307
4. Himms-Hagen J. In: Strasborg A.D. (Ed). The Beta 3-Adrenoreceptor (2000), Taylor & Francis Ltd., London 97-119 125-166
5. Collins S., and Surwit R.S. Recent Prog. Horm. Res. 56 (2001) 309
6. Sell H., Deshaies Y., and Richard D. Int. J. Biochem. Cell Biol. 36 (2004) 2098
7. Hatakeyama Y., Sakata Y., Takakura S., Manda T., and Mutoh S. Am. J. Physiol. 287 (2004) R336
8. Kiso T., Namikawa T., Tokunaga T., Sawada K., Kakita T., Shogaki T., and Ohtsubo Y. Biol. Pharm. Bull. 22 (1999) 1073
9. Atgie C., Faintrenie G., Carpene C., Bukowiecki L.J., and Geloen A. Comp. Biochem. Physiol. A: Physiol A (1998) 629
10. Arner Peter. Best Pract. Res. Clin. Endocrinol. Metab. 19 (2005) 471
11. Tavernier G., Barbe P., Galitzky J., Berlan M., Caput D., Lafontan M., and Langin D. J. Lipid Res. 37 (1996) 87
12. Van Baak M.A., Hul G.B.J., Toubro S., Astrup A., Gottesdiener K.M., DeSmet M., and Saris W.H.M. Clin. Pharmacol. Ther. 71 (2002) 272
13. Larsen T.M., Toubro S., van Baak M.A., Gottesdiener K.M., Larson P., Saris W.H.M., and Astrup A. Am. J. Clin. Nutr. 76 (2002) 780
14. Fletcher D.S., Candelore M.R., Grujic D., Lowell B.B., Luell S., Susulic V.S., and Macintyre D.E. J. Pharmacol. Exp. Ther. 287 (1998) 720
15. Summers R.J., Roberts S.J., Hutchinson D.S., and Evans B.A. Proc. West. Pharmacol. Soc. 42 (1999) 115
16. Fujimura T., Tamura K., Tsutsumi T., Yamamoto T., Nakamura K., Koibuchi Y., Kobayashi M., and Yamaguchi O. J. Urol. 161 (1999) 680
17. Smith C.P., and Chancellor M.B. Expert Opin. Ther. Pat. 11 (2001) 17
18. Kaumann A.J., and Molenaar P. Br. J. Pharmacol. 118 (1996) 2085
19. Malinowska B., and Schlicker E. Br. J. Pharmacol. 117 (1996) 943
20. Cohen M.L., Bloomquist W., Kriauciunas A., Shuker A., and Calligaro D. Br. J. Pharmacol. 126 (1999) 10189
21. Cohen M.L., Bloomquist W., Ito M., and Lowell B.B. Ion Channel 7 (2000) 17
22. Brahmadevara N., Shaw A.M., and MacDonald A.. Br. J. Pharmacol. 138 (2003) 99
23. Sarsero D., Molenaar P., and Kaumann A.J. Br. J. Pharmacol. 123 (1998) 371
24. Kaumann A.J., Preitner F., Sarsero D., Molenaar P., Revelli J.-P., and Giacobino J.P. Mol. Pharmacol. 53 (1998) 670
25. Kaumann A.J., Engelhardt S., Hein L., Molenaar P., and Lohse M. Naunyn-Schmiedeberg's Arch. Pharmacol. 363 (2001) 87
26. Siegel M.G., Shuker A.J., Droste C.A., Hahn P.J., Jesudason C.D., McDonald J.H., Matthews Jr. D.P., Rito C.J., and Thorpe A.J. Mol. Divers. 3 (1998) 113
27. Shuker A.J., Siegel M.G., Matthews D.P., and Weigel L.O. Tetrahedron Lett. 38 (1997) 6149
28. R = methyl was made via the mixed acetic/formic anhydride as described in. Krishnamurthy S. Tetrahedron Lett. 23 (1982) 3315
29. Rat atrial tachycardia was measured as described in Ref. 8c.
30. Chen Y., and Heiman M.L. Regul. Pept. 92 (2000) 113